Market Overview

Goldman Sachs Downgrades Aetna To Neutral

Related AET
Benzinga's Top Upgrades
Aetna 8-K Address Shareholder Class Action Suit

Analysts at Goldman Sachs downgraded Aetna (NYSE: AET) from Buy to Neutral.

The target price for Aetna has been lowered from $94.00 to $88.00.

Aetna shares have surged 24.00% over the past 52 weeks, while the S&P 500 index has gained 13.56% in the same period.

Aetna's shares dropped 0.61% to $77.84 in pre-market trading.

Latest Ratings for AET

Sep 2015Cantor FitzgeraldUpgradesHoldBuy
Sep 2015JP MorganInitiates Coverage onOverweight
Jul 2015Bank of AmericaUpgradesNeutralBuy

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: Goldman SachsDowngrades Analyst Ratings


Related Articles (AET)

View Comments and Join the Discussion!

Get Benzinga's Newsletters